Eboo Versi, MD PhD is the president and founder of the Versi Group.
He has over 30 years of experience as a physician, surgeon, academic, teacher, entrepreneur, investor, and senior executive. He is the inventor of several patents, and owns over thirty more U.S. and international patents under the Versi Group and its licensees.
Dr. Versi has served as a pharmaceutical executive at several large (Pfizer, Astellas) and small (Pliva, Mt Cook) companies in a medical capacity culminating as Chief Medical Officer, and head of drug development. Previously, he was the chief of Urogynecology at the Brigham & Women’s Hospital and an Associate Professor at Harvard Medical School.
Dr. Versi has published over 100 scientific articles in a variety of fields. He is a member of the Royal College of Obstetricians and Gynecologists and has been Chairman of the Research Committee of the American Urogynecologic Society, Chairman of the Socio-economic Committee of the International Consultation on Incontinence, member of the expert advisory panel in Urogynecology for FIGO and several ad hoc committees for the National Institutes of Health.
Dr. Versi received his Masters and Doctorate from Oxford University and Medical Degree from Cambridge University in the UK.
When he is not traveling, Dr. Versi can be found in north central New Jersey, spending time with his wife, three daughters, and cycling the nearby hills.
Jannine Versi is a strategic advisor to the Versi Group.
In 2014, Jannine was appointed by the White House to serve as a senior executive and chief of staff to the Under Secretary of Commerce for International Trade at the U.S. Department of Commerce. For two years, she helped to lead the International Trade Administration, a bureau of 2,200 professionals based in 75 countries that advances the competitiveness of U.S. business, promotes international trade and exports, and attracts foreign direct investment.
Prior to joining the Obama Administration, Jannine led product marketing initiatives at Google in the U.S., U.K., and Middle East, and worked for the CEO of Somnus Therapeutics in New Jersey.
Jannine holds an MBA from Harvard Business School, a BA from the University of Pennsylvania, and was a Fulbright scholar in India.